Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 1/20 | 0.43 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.43 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.43 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.43 |
| ▸ | PANK3 | Q9H999 | 9/20 | 0.43 |
| ▸ | LCAT | P04180 | 1/20 | 0.41 |
| ▸ | OGA | O60502 | 5/20 | 0.41 |
| ▸ | ACACB | O00763 | 1/20 | 0.40 |
| ▸ | SMO | Q99835 | 2/20 | 0.40 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.39 |
| ▸ | MTOR | P42345 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26702802 | 0.87 | PDE10A (0.45) | PANK3LCATOGAACACB | |
| SCHEMBL11989540 | 0.86 | OGA (0.40) | OPRM1OPRD1OPRK1OPRL1PANK3 | |
| SCHEMBL11990169 | 0.86 | LMNA (0.42) | OPRM1OPRD1OPRK1OPRL1PANK3 | |
| SCHEMBL23107193 | 0.83 | PANK3 (0.42) | PANK3LCATOGAACACBSMO | |
| SCHEMBL15247287 | 0.83 | PANK3 (0.41) | PANK3LCATOGAACACBSMO | |
| SCHEMBL15247290 | 0.82 | LCAT (0.44) | OPRM1OPRD1OPRK1OPRL1PANK3 | |
| SCHEMBL26845645 | 0.80 | OPRM1 (0.43) | OPRM1OPRD1OPRK1OPRL1PANK3 | |
| SCHEMBL14349207 | 0.79 | PANK3 (0.46) | PANK3OGAACACBSMO | |
| SCHEMBL13466366 | 0.79 | CNR2 (0.48) | PANK3OGAACACB | |
| SCHEMBL26702776 | 0.78 | OGA (0.42) | PANK3LCATOGAACACB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2815750-A1 | 5-cyano-4-(pyrrolo [2,3b] pyridine-3-yl)-pyrimidine derivatives useful as protein kinase inhibitors | Vertex Pharmaceuticals Incorporated (US) | 2014-12-24 | — | — | EP | disclosed |
| US-8530489-B2 | 5-cyano-4-(pyrrolo [2,3B] pyridine-3-yl)-pyrimidine derivatives useful as protein kinase inhibitors | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2013-09-10 | — | — | US | disclosed |
| WO-2008079346-A1 | 5-CYAN0-4- (PYRROLO [2, 3B] PYRIDINE-3-YL) -PYRIMIDINE DERIVATIVES USEFUL AS PROTEIN KINASE INHIBITORS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2008-07-03 | — | — | WO | disclosed |